The Effect of Ice Massage on Pain, Ecchymosis, Hematoma and Patient Satisfaction
Launched by ERZURUM TECHNICAL UNIVERSITY · Mar 25, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of ice massage on pain, bruising, and patient satisfaction for people undergoing hemodialysis through an arteriovenous fistula. The research aims to see if applying ice to the area before the procedure can help reduce pain and improve the overall experience for patients. If you are at least 18 years old, conscious, and able to communicate, you may be eligible to participate, provided there are no signs of infection in the area where the procedure will take place.
Participants in the study will receive an ice massage ten minutes before their hemodialysis treatment, and researchers will measure their pain levels and satisfaction afterward. It's important to note that if you have any signs of infection, are under 18, or have certain health conditions that might affect bleeding, you won't be able to join the study. This trial is not yet open for recruitment, but it aims to gather valuable information that could help improve the care and comfort of patients undergoing hemodialysis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Conscious and oriented
- • Communicable,
- • Those who are 18 years or older,
- • Hemodialysis treatment is applied via arteriovenous fistula,
- • There are no signs of infection such as redness, swelling, or open wound in the area where the procedure will be performed,
- • Patient: International Normalized Ratio: 2-3, Activated Partial Thromboplastin Time: 27-45 sec. Prothrombin Time: 11-16 sec. Thrombocyte: 125-350 m3
- • Can tolerate the application,
- • 10 minutes before starting Hemodialysis treatment. vissual analog scale pain score was evaluated beforehand and vissual analog scale was ≥4.
- • Patients who agree to participate in the study verbally and in writing will be included in the research.
- Exclusion Criteria:
- • Unconscious,
- • Unable to communicate,
- • Those who are under 18 years of age,
- • Hemodialysis treatment is not applied via arteriovenous fistula,
- • If there is any sign of infection such as redness, swelling, open wound in the area where cannulation will be performed,
- • 10 minutes before starting hemodialysis treatment. vissual analog scale pain score was evaluated beforehand and vissual analog scale ≤ 4
- • Using any painkillers before the procedure on the same day,
- • Patient: International Normalized Ratio: 2-3, Activated Partial Thromboplastin Time: 27-45 sec. Prothrombin Time: 11-16 sec. Thrombocyte: above 125-350 m3, prone to bleeding,
- • Patients who cannot tolerate the application or do not want to participate in the study voluntarily will not be included in the research.
- Exclusion Criteria:
- • Patients who cannot tolerate ice massage during the procedure will not be included in the study.
About Erzurum Technical University
Erzurum Technical University is a leading academic institution dedicated to advancing research and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its extensive expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the scientific community. With a commitment to ethical practices and collaboration, Erzurum Technical University fosters partnerships with healthcare providers and researchers to ensure the successful execution of clinical trials that adhere to the highest standards of quality and safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erzurum, Yakutiye, Turkey
Patients applied
Trial Officials
Ercan Bakır, PhD
Study Director
erzurum tecnical university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported